EarningsQ3 2024 Earnings Report

Astellas Pharma (4503N) Q3 2024 Earnings Report

1 Followers

MX:4503N Q3 2024 EPS Results

Actual EPS-$6.39

Consensus EPS$2.87

Beat/MissMissed by -$9.27

One Year Ago EPS$1.22

Actual Revenue$60.65B

Expected Revenue$52.46B

Beat/MissBeat by +$8.19B

YoY Revenue Growth+22.63%

QuarterQ3 2024

Date02/04/2025

TimeBefore Open

Conference CallTuesday, February 4, 2025

MX:4503N Upcoming Earnings

Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:4503N Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q2)	7.41 / -	5.183	―
Aug 05, 2026	2026 (Q1)	6.34 / 9.28	4.48	107.09% (+4.80)
Apr 27, 2026	2025 (Q4)	3.58 / 2.85	4.904	-41.95% (-2.06)
Feb 04, 2026	2025 (Q3)	5.38 / 6.57	-6.394	202.73% (+12.96)
Oct 30, 2025	2025 (Q2)	3.49 / 5.18	2.351	120.44% (+2.83)
Jul 30, 2025	2025 (Q1)	2.33 / 4.48	2.462	82.00% (+2.02)
Apr 25, 2025	2024 (Q4)	2.50 / 4.90	-2.175	325.50% (+7.08)
Feb 04, 2025	2024 (Q3)	2.87 / -6.39	1.219	-624.52% (-7.61)
Oct 30, 2024	2024 (Q2)	2.11 / 2.35	-0.094	2607.50% (+2.45)
Aug 01, 2024	2024 (Q1)	1.12 / 2.46	2.164	13.76% (+0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed